<VariationArchive RecordType="classified" VariationID="635754" VariationName="NM_003722.5(TP63):c.1350-75_1492del" VariationType="Deletion" Accession="VCV000635754" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-17" DateCreated="2019-07-14" MostRecentSubmission="2019-07-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="623592" VariationID="635754">
      <GeneList>
        <Gene Symbol="TP63" FullName="tumor protein p63" GeneID="8626" HGNC_ID="HGNC:15979" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="189596746" stop="189897276" display_start="189596746" display_stop="189897276" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="189349215" stop="189615067" display_start="189349215" display_stop="189615067" Strand="+" />
          </Location>
          <OMIM>603273</OMIM>
          <Haploinsufficiency last_evaluated="2012-09-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TP63">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-09-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TP63">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003722.5(TP63):c.1350-75_1492del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="189886318" stop="189886535" display_start="189886318" display_stop="189886535" variantLength="218" positionVCF="189886317" referenceAlleleVCF="AGAGACCTGTTGAAAATCAATAGTCCCCACTCTTCAGTGTCCCTTGCTCACCATTATTTCCATGTTTGTCTTCCTAGGACCTCAATACAGTCTCCATCTTCATATGGTAACAGCTCCCCACCTCTGAACAAAATGAACAGCATGAACAAGCTGCCTTCTGTGAGCCAGCTTATCAACCCTCAGCAGCGCAACGCCCTCACTCCTACAACCATTCCTGAT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="189604107" stop="189604324" display_start="189604107" display_stop="189604324" variantLength="218" positionVCF="189604106" referenceAlleleVCF="AGAGACCTGTTGAAAATCAATAGTCCCCACTCTTCAGTGTCCCTTGCTCACCATTATTTCCATGTTTGTCTTCCTAGGACCTCAATACAGTCTCCATCTTCATATGGTAACAGCTCCCCACCTCTGAACAAAATGAACAGCATGAACAAGCTGCCTTCTGTGAGCCAGCTTATCAACCCTCAGCAGCGCAACGCCCTCACTCCTACAACCATTCCTGAT" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.189604108_189604325del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.189604108_189604325del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.189886319_189886536del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.189886319_189886536del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007550.3" sequenceAccession="NG_007550" sequenceVersion="3" change="g.294574_294791del">
            <Expression>NG_007550.3:g.294574_294791del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329964.2" sequenceAccession="NM_001329964" sequenceVersion="2" change="c.1344-75_1486del">
            <Expression>NM_001329964.2:c.1344-75_1486del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003722.5" sequenceAccession="NM_003722" sequenceVersion="5" change="c.1350-75_1492del" MANESelect="true">
            <Expression>NM_003722.5:c.1350-75_1492del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114978.2" sequenceAccession="NM_001114978" sequenceVersion="2" change="c.1350-75_1492del">
            <Expression>NM_001114978.2:c.1350-75_1492del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329144.2" sequenceAccession="NM_001329144" sequenceVersion="2" change="c.1350-75_1492del">
            <Expression>NM_001329144.2:c.1350-75_1492del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329148.2" sequenceAccession="NM_001329148" sequenceVersion="2" change="c.1338-75_1480del">
            <Expression>NM_001329148.2:c.1338-75_1480del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114980.2" sequenceAccession="NM_001114980" sequenceVersion="2" change="c.1068-75_1210del" MANEPlusClinical="true">
            <Expression>NM_001114980.2:c.1068-75_1210del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114981.2" sequenceAccession="NM_001114981" sequenceVersion="2" change="c.1068-75_1210del">
            <Expression>NM_001114981.2:c.1068-75_1210del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329145.2" sequenceAccession="NM_001329145" sequenceVersion="2" change="c.1068-75_1210del">
            <Expression>NM_001329145.2:c.1068-75_1210del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329149.2" sequenceAccession="NM_001329149" sequenceVersion="2" change="c.1056-75_1198del">
            <Expression>NM_001329149.2:c.1056-75_1198del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329146.2" sequenceAccession="NM_001329146" sequenceVersion="2" change="c.813-75_955del">
            <Expression>NM_001329146.2:c.813-75_955del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329150.2" sequenceAccession="NM_001329150" sequenceVersion="2" change="c.801-75_943del">
            <Expression>NM_001329150.2:c.801-75_943del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_428" sequenceAccession="LRG_428">
            <Expression>LRG_428:g.294574_294791del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_428t1" sequenceAccession="LRG_428t1">
            <Expression>LRG_428t1:c.1350-75_1492del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1577195893" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003722.5(TP63):c.1350-75_1492del AND Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3" Accession="RCV000787270" Version="1">
        <ClassifiedConditionList TraitSetID="1808">
          <ClassifiedCondition DB="MedGen" ID="C1858562">Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-05-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-05-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-07-14" MostRecentSubmission="2019-07-14">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1808" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1584" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3</ElementValue>
                <XRef ID="MONDO:0011428" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ectrodactyly, Ectodermal Dysplasia, Clefting Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3</ElementValue>
                <XRef ID="EEC+Syndrome/2477" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ectrodactyly, Ectodermal Dysplasia, Clefting Syndrome Type 3 (EEC3)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EEC SYNDROME 3</ElementValue>
                <XRef Type="MIM" ID="604292" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EEC3</ElementValue>
                <XRef Type="MIM" ID="604292" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The TP63-related disorders comprise six overlapping phenotypes: Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome (which includes Rapp-Hodgkin syndrome). Acro-dermo-ungual-lacrimal-tooth (ADULT) syndrome. Ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3 (EEC3). Limb-mammary syndrome. Split-hand/foot malformation type 4 (SHFM4). Isolated cleft lip/cleft palate (orofacial cleft 8). Individuals typically have varying combinations of ectodermal dysplasia (hypohidrosis, nail dysplasia, sparse hair, tooth abnormalities), cleft lip/palate, split-hand/foot malformation/syndactyly, lacrimal duct obstruction, hypopigmentation, hypoplastic breasts and/or nipples, and hypospadias. Findings associated with a single phenotype include ankyloblepharon filiforme adnatum (tissue strands that completely or partially fuse the upper and lower eyelids), skin erosions especially on the scalp associated with areas of scarring, and alopecia, trismus, and excessive freckling.</Attribute>
                <XRef ID="NBK43797" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TP63-Related Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20556892</ID>
                <ID Source="BookShelf">NBK43797</ID>
              </Citation>
              <XRef ID="1896" DB="Orphanet" />
              <XRef ID="C1858562" DB="MedGen" />
              <XRef ID="MONDO:0011428" DB="MONDO" />
              <XRef Type="MIM" ID="604292" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1811369" SubmissionDate="2019-06-09" DateLastUpdated="2019-07-14" DateCreated="2019-07-14">
        <ClinVarSubmissionID localKey="NM_003722.4:c.1350-75_1492del|OMIM:604292" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000926197" DateUpdated="2019-07-14" DateCreated="2019-07-14" Type="SCV" Version="1" SubmitterName="Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust" OrgID="505647" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-03">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TP63" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003722.4:c.1350-75_1492del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604292" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5746954</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1811369" TraitType="Disease" MappingType="XRef" MappingValue="604292" MappingRef="OMIM">
        <MedGen CUI="C1858562" Name="Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

